CLINICAL_TRIALS
trial_result
· 2023-09-21
Clinical Trial Update: A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes [Phase 3]
Summary
Phase 3 study evaluating two doses of dulaglutide (LY2189265) in Japanese patients with Type 2 diabetes, with results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2023-09-21